← FDA Drug Approvals (Drugs@FDA)

LIDOCAINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ABRAXIS PHARM · Approved 1972-02-15

Drug application

FDA Application #

ANDA080420

Application type

Abbreviated New Drug Application (Generic)

Brand name

LIDOCAINE HYDROCHLORIDE

Generic name

Lidocaine Hydrochloride

Active ingredients

LIDOCAINE HYDROCHLORIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

ABRAXIS PHARM

First approval

1972-02-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown